The Cooper Companies, IncCOO
▼ NegativeCapitalrelevance
Q2 CY2026 sales of $1.07B missed estimates and full-year revenue and EPS guidance were both lowered.
Impact on stocks 1
Aging Population
The Cooper Companies, IncCooperCompanies reported Q2 CY2026 sales of $1.07 billion, flat year on year and below analyst estimates of $1.10 billion, causing its stock to drop 16.8% to $52.91. The company's adjusted EPS of $1.15 beat expectations by 2.7%, but it lowered its full-year revenue guidance to $4.24 billion at the midpoint, a 1.5% cut, and reduced its adjusted EPS guidance to $4.53, a 1.9% decrease. Organic revenue rose only 1% year on year, missing estimates, while operating margin improved to 20.8% from 16.6% a year ago. CEO Al White noted that reduced U.S. channel inventory at CooperVision weighed on results and will continue to impact Q4, but highlighted record free cash flow and solid fertility growth at CooperSurgical.
The Cooper Companies, IncQ2 CY2026 sales of $1.07B missed estimates and full-year revenue and EPS guidance were both lowered.